U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 39

1.
LncRNA HCP5 Facilitates the Progression of Ovarian Cancer by Interacting with the PTBP1 Protein
Jian Shou, Chuanling Zhang, Xiaoyu Zheng, Yaowei Li, Peng Wu, Long Chen, XiuJun Wei
Biochem Genet. 2024; 62(4): 3136–3154. Published online 2023 Dec 10. doi: 10.1007/s10528-023-10558-8
PMCID:
PMC11289333
AbstractArticlePDF–3.5M
2.
HCP5 prevents ubiquitination-mediated UTP3 degradation to inhibit apoptosis by activating c-Myc transcriptional activity
Yabing Nan, Qingyu Luo, Xiaowei Wu, Wan Chang, Pengfei Zhao, Shi Liu, Zhihua Liu
Mol Ther. 2023 Feb 1; 31(2): 552–568. Published online 2022 Oct 17. doi: 10.1016/j.ymthe.2022.10.006
PMCID:
PMC9931552
AbstractArticlePDF–5.4M
3.
HLA complex P5 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma
Yaqin Wang, Zhijun Yu, Weidong Shi, Jian Shen, Yun Guan, Feng Ni
Bioengineered. 2022; 13(4): 9302–9312. Published online 2022 Apr 7. doi: 10.1080/21655979.2022.2051854
PMCID:
PMC9208456
AbstractArticlePDF–3.1M
4.
LncRNA HCP5 Participates in the Tregs Functions in Allergic Rhinitis and Drives Airway Mucosal Inflammatory Response in the Nasal Epithelial Cells
Chen Yang, Chengfang Shangguan, Changing Cai, Jing Xu, Xiaohua Qian
Inflammation. 2022; 45(3): 1281–1297. Published online 2022 Feb 5. doi: 10.1007/s10753-022-01620-5
PMCID:
PMC9095562
AbstractArticlePDF–5.5M
5.
Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells
Derong Yin, Xiaohong Lu
Bioengineered. 2021; 12(1): 225–239. Published online 2020 Dec 29. doi: 10.1080/21655979.2020.1863619
PMCID:
PMC8806318
AbstractArticlePDF–9.5M
6.
Knockdown long non-coding RNA HCP5 enhances the radiosensitivity of esophageal carcinoma by modulating AKT signaling activation
Yue Guo, Lan Wang, Hui Yang, Nannan Ding
Bioengineered. 2022; 13(1): 884–893. Published online 2021 Dec 30. doi: 10.1080/21655979.2021.2014386
PMCID:
PMC8805942
AbstractArticlePDF–2.2M
7.
LncRNA HCP5 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/mTOR signaling
Jianyu Xu, Jianli Ma, Bixi Guan, Jian Li, Yan Wang, Songliu Hu
Cell Cycle. 2021; 20(14): 1374–1388. Published online 2021 Jun 30. doi: 10.1080/15384101.2021.1944512
PMCID:
PMC8344760
AbstractArticlePDF–5.4M
8.
lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR-138-5p in cutaneous squamous cell carcinoma
Shibo Zou, Ya Gao, Shutang Zhang
Int J Oncol. 2021 Aug; 59(2): 56. Published online 2021 Jun 29. doi: 10.3892/ijo.2021.5236
PMCID:
PMC8253586
AbstractArticlePDF–2.1M
9.
HCP5, as the sponge of miR-1291, facilitates AML cell proliferation and restrains apoptosis via increasing PIK3R5 expression
Yan Liu, Xue-Bing Jing, Zhen-Cheng Wang, Qing-Kun Han
Hum Genomics. 2021; 15: 38. Published online 2021 Jun 29. doi: 10.1186/s40246-021-00340-5
PMCID:
PMC8244151
AbstractArticlePDF–2.4M
10.
LncRNA HCP5 knockdown inhibits high glucose-induced excessive proliferation, fibrosis and inflammation of human glomerular mesangial cells by regulating the miR-93-5p/HMGA2 axis
Xuan Wang, Yan Liu, Jian Rong, Kai Wang
BMC Endocr Disord. 2021; 21: 134. Published online 2021 Jun 29. doi: 10.1186/s12902-021-00781-y
PMCID:
PMC8243433
AbstractArticlePDF–4.0M
11.
HCP5 contributes to cisplatin resistance in gastric cancer through miR-128/HMGA2 axis
Liqun Liang, Hongchun Kang, Junmei Jia
Cell Cycle. 2021; 20(11): 1080–1090. Published online 2021 May 16. doi: 10.1080/15384101.2021.1924948
PMCID:
PMC8208113
AbstractArticlePDF–2.9M
12.
MEF2A-mediated lncRNA HCP5 Inhibits Gastric Cancer Progression via MiR-106b-5p/p21 Axis
Weiwei Chen, Kundong Zhang, Yuhan Yang, Zengya Guo, Xiaofeng Wang, Buwei Teng, Qian Zhao, Chen Huang, Zhengjun Qiu
Int J Biol Sci. 2021; 17(2): 623–634. Published online 2021 Jan 16. doi: 10.7150/ijbs.55020
PMCID:
PMC7893594
AbstractArticlePDF–2.6M
13.
Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma
Yangmao Tu, Qing Cai, Xuemei Zhu, Min Xu
Braz J Med Biol Res. 2021; 54(2): e9161. Published online 2021 Jan 8. doi: 10.1590/1414-431X20209161
PMCID:
PMC7798137
AbstractArticlePDF–1.1M
14.
T Cell Factor 4 Is Involved in Papillary Thyroid Carcinoma via Regulating Long Non-Coding RNA HCP5
Rui Wang, Jidong Cai, Shangnao Xie, Chunlei Zhao, Yi Wang, Deming Cao, Gang Li
Technol Cancer Res Treat. 2020; 19: 1533033820983290. Published online 2020 Dec 28. doi: 10.1177/1533033820983290
PMCID:
PMC7780308
AbstractArticlePDF–2.1M
15.
An Intronic HCP5 Variant Is Associated With Age of Onset and Susceptibility to Graves Disease in UK and Polish Cohorts
Laura Claire Lane, Aleksander Kuś, Tomasz Bednarczuk, Artur Bossowski, Jacek Daroszewski, Beata Jurecka-Lubieniecka, Heather Jane Cordell, Simon Henry Schofield Pearce, Timothy Cheetham, Anna Louise Mitchell
J Clin Endocrinol Metab. 2020 Sep; 105(9): e3277–e3284. Published online 2020 Jun 5. doi: 10.1210/clinem/dgaa347
PMCID:
PMC7382372
AbstractArticle
16.
The Effect of Long Non-Coding RNA (lncRNA) HCP5 on Regulating Epithelial-Mesenchymal Transition (EMT)-Related Markers in Gastric Carcinoma Is Partially Reversed by miR-27b-3p
Shudong Chen, Chenglei Ren, Hui Zheng, Xianchun Sun, Jundi Dai
Med Sci Monit. 2020; 26: e921383-1–e921383-12. Prepublished online 2020 Mar 6. Published online 2020 May 1. doi: 10.12659/MSM.921383
PMCID:
PMC7212807
AbstractArticlePDF–1.5M
17.
Long noncoding RNA HCP5 participates in premature ovarian insufficiency by transcriptionally regulating MSH5 and DNA damage repair via YB1
Xiaoyan Wang, Xinyue Zhang, Yujie Dang, Duan Li, Gang Lu, Wai-Yee Chan, Peter C K Leung, Shidou Zhao, Yingying Qin, Zi-Jiang Chen
Nucleic Acids Res. 2020 May 7; 48(8): 4480–4491. Published online 2020 Feb 29. doi: 10.1093/nar/gkaa127
PMCID:
PMC7192606
AbstractArticlePDF–3.3M
18.
MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer
Honglei Wu, Bin Liu, Zhaosheng Chen, Guangchun Li, Zhen Zhang
Cell Death Dis. 2020 Apr; 11(4): 233. Published online 2020 Apr 16. doi: 10.1038/s41419-020-2426-z
PMCID:
PMC7162922
AbstractArticlePDF–4.5M
19.
LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR‐219a‐5p
Lihong Wang, Tian Luan, Shunheng Zhou, Jing Lin, Yue Yang, Wei Liu, Xiao Tong, Wei Jiang
Cancer Med. 2019 Aug; 8(9): 4389–4403. Published online 2019 Jun 18. doi: 10.1002/cam4.2335
PMCID:
PMC6675706
AbstractArticlePDF–939K
20.
Long Noncoding RNA HCP5, a Hybrid HLA Class I Endogenous Retroviral Gene: Structure, Expression, and Disease Associations
Jerzy K. Kulski
Cells. 2019 May; 8(5): 480. Published online 2019 May 20. doi: 10.3390/cells8050480
PMCID:
PMC6562477
AbstractArticlePDF–2.2M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center